Feed ALC
AL

Alcon

ALC · NYSE

$64.11 +1.55% (+$0.98)
1M -7.75%
Market Cap $30.8B
P/E Ratio 48.16x
Div. Yield 0.57%
ROE 2.91%

Bulios Fair Price

$39.93

37.7% downside

Trenutna cena

$64.11

Podcenjeno Poštena vrednost Precenjeno

Po podatkih Bulios Fair Price je delnica ALC trenutno precenjena glede na svojo tržno ceno. Kako deluje?

Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?

Analiza

AI poročilo o poslu, financah, vrednotenju, razpoloženju, novicah in tveganjih - napisano v nekaj minutah.

Piotroski F-Score Strong
8/9
Valuation
46 /100
Fair
EV/EBITDA 19.76x
P/S 2.85x
P/B 1.43x
Growth
77 /100
Growing
Rev. growth 6.06%
FCF growth 54.12%
Book val. growth 3.84%
Profitability
68 /100
Strong
Net margin 5.92%
Op. margin 9.87%
FCF margin 15.57%
Quality
16 /100
Poor
ROE 2.91%
ROA 2.06%
Asset turnover 0.35x
Debt
75 /100
Low
Current ratio 2.09x
Int. coverage 4.29x
Net debt/EBITDA 2.24x
Stability
68 /100
Stable
Rev. volatility 2.07%
EPS volatility 108.41%
Profitable years 5

Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več

Vprašajte StockBota o ALC
Online

O podjetju

Alcon Inc. (ALC) is a global company operating in the field of ophthalmology and eye care. The company specializes in the development, manufacturing, and distribution of a wide range of eye products, including pharmaceuticals, medical devices, and surgical instruments. Alcon focuses on various eye conditions and issues, including cataracts, glaucoma, macular degeneration, and other eye diseases. Its products and technologies are used in both diagnosis and treatment of eye conditions, helping to improve vision and the quality of life for patients. Alcon has a long history and is recognized as a leader in the field of ophthalmology. The company continually strives to innovate and develop new technologies and treatment approaches to enhance eye care worldwide. Alcon Inc. (ALC) shares may be an attractive investment opportunity for investors interested in the healthcare sector and seeking an investment in a company specializing in ophthalmology and eye care.

V vašem jeziku še ni na voljo, zato je besedilo v angleščini.

Sector

Healthcare

Industry

Medical - Specialties

CEO

David J. Endicott

Employees

25,000

Headquarters

Geneva

Prihajajoči dogodki

10 NOV.

Earnings

Upcoming earnings report

32d

Uporabljamo nujne piškotke za delovanje spletnega mesta in izbirne analitične piškotke za merjenje uporabe. Preberite naš Pravilnik o zasebnosti.